poisar

Stock

Treace Medical Concepts, Inc. TMCI

$4.61-2.54%

Overview

TMCI market data

Price History

TMCI price chart · 1M
O
4.74
H
4.78
L
4.42
C
4.61
Vol
14,125.00
Source
US equities market feed
Observed
Aug 27, 2026, 12:00 AM
Cadence
Five-minute page cache; daily and stored hourly bars
Status
fresh

Key Stats & Performance

Open
$4.74
Previous Close
$4.73
Day High
$4.78
Day Low
$4.42
52 Week High
$5.14
52 Week Low
$1.72
7 Day Return
+3.71%
30 Day Return
+14.96%
90 Day Return
+33.04%
1 Year Return
+161.93%
Daily Notional Volume
$65.1K
Latest daily bar volume multiplied by its closing price.

Valuation & Profitability

Provider-backed
P/E (TTM)
Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
Forward P/E
P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
EPS (TTM)
-$0.93
Diluted earnings per share over the trailing twelve months.
Beta
1.48
Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
Dividend Yield
Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
Profit Margin
-29.4%
Net income divided by revenue. Comparable within a sector, less so across sectors.
52w range
$1.17 – $7.65
Lowest and highest closing prices over the past 52 weeks.
Analyst Target
Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.

Display-only. Refreshed once per symbol per 24 hours · market cap $293.3M · P/B 1.79 · P/S 1.41.

Company News

7 captured
Truist Securities Maintains Hold on Treace Medical Concepts, Raises Price Target to $5Benzinga · Aug 10, 2026, 6:21 PM
Treace Medical Concepts shares are trading higher after the company reported better-than-expected Q2 financial results and raised its FY26 sales guidance.Benzinga · Aug 7, 2026, 12:45 PM
8-K filing — TREACE MEDICAL CONCEPTS, INC. (TMCI)SEC EDGAR · Aug 7, 2026, 11:10 AM
Treace Medical Concepts Q2 EPS $(0.24) Beats $(0.30) Estimate, Sales $45.376M Beat $44.020M EstimateBenzinga · Aug 7, 2026, 11:06 AM
Treace Medical Concepts Raises FY2026 Sales Guidance from $202.000M-$212.000M to $204.000M-$212.000M vs $206.220M EstBenzinga · Aug 7, 2026, 11:05 AM
Truist Securities Maintains Hold on Treace Medical Concepts, Raises Price Target to $4Benzinga · Jul 16, 2026, 5:06 PM
Treace Medical Concepts Announces Completion Of First Case Utilizing Its HyperPlate XM Dynamic Compression Locking Implant, Complete Commercialization Expected in Q3 of 2026Benzinga · Jun 18, 2026, 11:15 AM

Decision & Score

Members

Our Tradable / Watch / Avoid decision and 0–100 conviction score for this symbol are members-only.

Create account to unlock

Trend & Pattern Evidence

Members

Trend alignment and backtested chart-pattern probabilities are members-only.

Create account to unlock

Sector Peer Ranking

Members

Ranked sector peers with scores and decisions are members-only.

Create account to unlock